image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Glisten - Second cereal bar aquisition

February 2006

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • GLI
  • Price:
  • 330p
The shares stormed to a new high following Glisten’s acquisition of Lyme Regis Fine Foods, which specialises in the manufacture and supply of organic cereal and fruit / snack bars to both major retailers and health-food outlets. Lyme Regis, which is based in Liphook, Hampshire, generated an operating profit of £0.5m on sales of £3.6m in the year ended 31 December 2004 and will fit well with Glisten’s other cereal bar acquisition, Halo Foods. Glisten has not disclosed the consideration for Lyme Regis, except to say that gearing, following the acquisition, will amount to 70%, while the deal is expected to be earnings enhancing in the 2006/7 financial year. The vendor will receive part of the initial consideration in ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X